443 related articles for article (PubMed ID: 22583443)
1. In vitro and in vivo models of multiple sclerosis.
van der Star BJ; Vogel DY; Kipp M; Puentes F; Baker D; Amor S
CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443
[TBL] [Abstract][Full Text] [Related]
2. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.
Rodriguez M
Brain Pathol; 2007 Apr; 17(2):219-29. PubMed ID: 17388953
[TBL] [Abstract][Full Text] [Related]
3. Deleterious versus protective autoimmunity in multiple sclerosis.
Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
[TBL] [Abstract][Full Text] [Related]
4. Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.
Mecha M; Carrillo-Salinas FJ; Mestre L; Feliú A; Guaza C
Prog Neurobiol; 2013; 101-102():46-64. PubMed ID: 23201558
[TBL] [Abstract][Full Text] [Related]
5. Promotion of endogenous remyelination in multiple sclerosis.
Lucchinetti CF; Noseworthy JH; Rodriguez M
Mult Scler; 1997 Apr; 3(2):71-5. PubMed ID: 9291156
[TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration in autoimmune CNS inflammation.
Herz J; Zipp F; Siffrin V
Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis.
Hamilton AM; Forkert ND; Yang R; Wu Y; Rogers JA; Yong VW; Dunn JF
Sci Rep; 2019 Jun; 9(1):8488. PubMed ID: 31186441
[TBL] [Abstract][Full Text] [Related]
8. Experimental models of multiple sclerosis.
Pachner AR
Curr Opin Neurol; 2011 Jun; 24(3):291-9. PubMed ID: 21519255
[TBL] [Abstract][Full Text] [Related]
9. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Mokhtarian F; Safavi F; Sarafraz-Yazdi E
Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.
Seyedsadr MS; Weinmann O; Amorim A; Ineichen BV; Egger M; Mirnajafi-Zadeh J; Becher B; Javan M; Schwab ME
Neurobiol Dis; 2019 Apr; 124():189-201. PubMed ID: 30468865
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH
Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of multiple sclerosis: an update on immunology.
Hemmer B; Cepok S; Nessler S; Sommer N
Curr Opin Neurol; 2002 Jun; 15(3):227-31. PubMed ID: 12045717
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
Stinissen P; Raus J; Zhang J
Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
[TBL] [Abstract][Full Text] [Related]
15. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Nastasijevic B; Wright BR; Smestad J; Warrington AE; Rodriguez M; Maher LJ
PLoS One; 2012; 7(6):e39595. PubMed ID: 22761835
[TBL] [Abstract][Full Text] [Related]
16. Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond.
Kipp M; van der Star B; Vogel DY; Puentes F; van der Valk P; Baker D; Amor S
Mult Scler Relat Disord; 2012 Jan; 1(1):15-28. PubMed ID: 25876447
[TBL] [Abstract][Full Text] [Related]
17. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
Skundric DS
Curr Neurovasc Res; 2005 Oct; 2(4):349-62. PubMed ID: 16181126
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of multiple sclerosis: lost in translation?
Baker D; Amor S
Curr Pharm Des; 2015; 21(18):2440-52. PubMed ID: 25777759
[TBL] [Abstract][Full Text] [Related]
19. Experimental models of demyelination and remyelination.
Torre-Fuentes L; Moreno-Jiménez L; Pytel V; Matías-Guiu JA; Gómez-Pinedo U; Matías-Guiu J
Neurologia (Engl Ed); 2020; 35(1):32-39. PubMed ID: 28863829
[TBL] [Abstract][Full Text] [Related]
20. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
Dal Canto MC; Melvold RW; Kim BS; Miller SD
Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
